BioNTech has billions in cash, and its oncology programs are moving into late-stage clinical trials.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
Alpaca · SIPUpdated 12:19 NY15 Minutes Delayed
Which Real Estate ETF Is the Better Buy: State Street’s XLRE or Northern Trust’s Global GQRE?
Yahoo38 Minutes Ago
You Can Do Better Than Nike. Buy This High-Yield Dividend Stock Instead.
Yahoo45 Minutes Ago
Chipotle Hit a 52-Week Low Last Week. Here’s What RBC’s Upside Call Needs on October 28
Yahoo54 Minutes Ago
Target wants to win customers, but price cuts miss the mark
Yahoo1 Hour Ago
HCA Healthcare Reports Q3 Adjusted EPS of $7.22, Raises Expectations Within 2026 Guidance Range
Yahoo1 Hour Ago
